Singapore markets close in 3 hours 2 minutes
  • Straits Times Index

    3,293.85
    +9.91 (+0.30%)
     
  • Nikkei

    27,818.06
    +350.83 (+1.28%)
     
  • Hang Seng

    24,752.06
    +624.21 (+2.59%)
     
  • FTSE 100

    7,589.66
    +26.11 (+0.35%)
     
  • BTC-USD

    41,885.45
    +137.23 (+0.33%)
     
  • CMC Crypto 200

    994.55
    -0.20 (-0.02%)
     
  • S&P 500

    4,532.76
    -44.35 (-0.97%)
     
  • Dow

    35,028.65
    -339.85 (-0.96%)
     
  • Nasdaq

    14,340.25
    -166.65 (-1.15%)
     
  • Gold

    1,839.90
    -3.30 (-0.18%)
     
  • Crude Oil

    86.95
    -0.01 (-0.01%)
     
  • 10-Yr Bond

    1.8270
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,529.29
    -1.04 (-0.07%)
     
  • Jakarta Composite Index

    6,630.82
    +38.84 (+0.59%)
     
  • PSE Index

    7,239.28
    -22.26 (-0.31%)
     

Moderna, Regeneron, Meta Platforms Fall Premarket; Twitter Rises

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Tuesday, November 30th. Please refresh for updates.

Meta Platforms (NASDAQ:FB) stock fell 0.6% after Britain's antitrust regulator directed Facebook’s owner to sell animated images platform Giphy for competitive reasons.

Twitter (NYSE:TWTR) stock rose 0.8%, continuing the social media giant’s volatile trading after founder and CEO Jack Dorsey said on Monday he would step down from the company.

Moderna (NASDAQ:MRNA) stock fell 2.6% after CEO Stephane Bancel told the Financial Times that it was likely the drugmaker’s vaccine would likely have to be adjusted to cope with the omicron variant of Covid-19.

Regeneron (NASDAQ:REGN) stock fell 1.4% after the pharmaceutical company said its Covid-19 antibody drug could have reduced activity against the new variant.

American Airlines (NASDAQ:AAL) stock fell 1.9%, Delta (NYSE:DAL) stock fell 1.8% and United (NASDAQ:UAL) stock fell 2% as travel stocks suffered, while cruise operators Carnival (NYSE:CUK) and Norwegian Cruise Line (NYSE:NCLH) both dropped over 2%. Retail, casino and hotel stocks were also broadly lower.

Exxon Mobil (NYSE:XOM) stock fell 1.9%, Chevron (NYSE:CVX) stock dropped 1.8% and Occidental Petroleum (NYSE:OXY) stock slipped 3%, as oil prices fell more than 2% on demand concerns.

Netflix (NASDAQ:NFLX) stock rose 0.6%, Peloton (NASDAQ:PTON) stock rose 1.2% and Zoom Video (NASDAQ:ZM) stock rose 1.7%, with these stay-at-home stocks benefiting from the increased uncertainty over the omicron variant.

Bank of America (NYSE:BAC) stock fell 2%, Wells Fargo (NYSE:WFC) stock dropped 1.7% and Citigroup (NYSE:C) stock fell 1.8% as the Wall Street lenders tracked a dip in Treasury yields.

Dollar Tree (NASDAQ:DLTR) stock fell 2.9% after Goldman Sachs downgraded its investment stance on the discount retailer to ‘neutral’ from ‘buy’, saying the stock is getting too expensive.

SolarEdge Technologies (NASDAQ:SEDG) stock fell 3.2% after Morgan Stanley downgraded the company to ‘equal-weight’ from ‘overweight’, saying the stock is at the end of its run.

Intuit (NASDAQ:INTU) stock fell 4.3% after the financial software company announced the secondary offering of over 1.5 million shares of common stock.

Related Articles

Moderna, Regeneron, Meta Platforms Fall Premarket; Twitter Rises

Wall Street Opens Lower on Omicron Fears; Dow Down 260 Points

COVID comeback caps a November to remember in markets

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting